1. Molecular typing of multi-drug resistant Candida albicans isolated from the Segamat community, Malaysia
- Author
-
Chuen Zhang Lee, Nazmul Hasan Muzahid, Calvin Bok Sun Goh, Marie Andrea Laetitia Huët, Joash Ban Lee Tan, Jacky Dwiyanto, and Sadequr Rahman
- Subjects
medicine.medical_specialty ,Antifungal Agents ,Microbial Sensitivity Tests ,Drug resistance ,Microbiology ,Medical microbiology ,Drug Resistance, Fungal ,Candida albicans ,Media Technology ,medicine ,Humans ,Typing ,Voriconazole ,biology ,Candidiasis ,Malaysia ,biology.organism_classification ,Drug Resistance, Multiple ,Corpus albicans ,Fungal and Bacterial Physiology - Short Communication ,Multilocus sequence typing ,Fluconazole ,Multilocus Sequence Typing ,medicine.drug - Abstract
In the past decade, researchers have focused on the emergence of drug resistance in fungal pathogens such as Candida albicans, also considered as pathobionts that occur harmlessly in the human body but could potentially be triggered to cause diseases. The increasing rate of antifungal resistance in commensal gut fungi is alarming and should be further investigated. Here, we report seven novel MLST (Multi Locus Sequence Typing) genotypes of multi-drug resistant C. albicans isolates obtained from participants of a community study in Segamat, a district in the state of Johor, Malaysia. A total of eight C. albicans were isolated from four individuals, which were found to express high resistance against fluconazole, itraconazole, voriconazole and 5-fluorocytosine antifungals. MLST was performed to assess the clonal relatedness of these drug resistant isolates among themselves and against other strains isolated from other geographical regions. The novel MLST C. albicans sequence types suggest significant genetic changes compared to previous genotypes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42770-021-00558-4.
- Published
- 2021
- Full Text
- View/download PDF